Johnson & Johnson Interventional Oncology - Roadshow

Join our Johnson & Johnson Interventional Oncology (INTO) and Oncology teams to:

- Learn how J&J’s external innovation model drives partnering

- Get an overview of our Interventional Oncology and Oncology strategies and current sourcing priorities

- Explore partnership opportunities to advance intratumoral and relevant systemic therapies into and through the clinic

- Network with entrepreneurs, start-ups, biotech leaders, and investors

PROGRAMME

23 October 2025 - Beyond the Needle: Building the future of intratumoral oncology

16:00 – 16:30, Registration

16:30 – 16:35, Welcome

Martyna Wroblewska, Manager Innovation & Sourcing, BaseLaunch (co-host)

Kai Stoeber, Senior Director External Innovation, Interventional Oncology, Johnson & Johnson

16:35 – 16:50, Overview of J&J in Switzerland & the J&J External Innovation model

Michael Hübner, Director Search & Evaluation, Johnson & Johnson

16:50 – 17:00,  Oncology at J&J: Priority disease areas
Sonal Patel, VP Oncology External Innovation, Johnson & Johnson

17:00 – 17:15, J&J Interventional Oncology: Strategy and sourcing priorities
Stewart Bates, Executive Director Head of Discovery & Translational Sciences, Interventional Oncology, Johnson & Johnson

17:15 – 17:25, Q&A

17:25 – 18:00,  Panel discussion - Beyond the needle: Building the future of intratumoral oncology
Moderator: Kai Stoeber, Senior Director External Innovation INTO, Johnson & Johnson

Panelist: Stewart Bates, Head of Discovery & Translational Sciences, Interventional Oncology, Johnson & Johnson

Panelist: Robert Aleksandrowicz, CEO, Cellis AG

Panelist: Fabio Rosa, Co-founder & Head of Research, Asgard Therapeutics
18:00 – 18:15, Q&A with panel

18:15 – 19:30, Networking reception

Location:

MC3 Main Campus Convention Center
167D Hegenheimermattweg
Allschwil BL 4123

Event is free of charge, but upon registration only.